TP53 and melanoma: The identification of a small subset of tumors with sequential TEAZ showing no tp53 alterations suggests that tp53 loss is sufficient but not necessary for melanoma progression, raising the possibility of non-specific genetic events that result from the TEAZ/TOL2 process (Fig. 5D).